UBS AM’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-631,593
Closed -$15M 2722
2015
Q4
$15M Sell
631,593
-100,951
-14% -$2.35M 0.02% 763
2015
Q3
$14.6M Buy
732,544
+34,099
+5% +$682K 0.02% 769
2015
Q2
$13.5M Sell
698,445
-316,466
-31% -$6.55M 0.01% 807
2015
Q1
$23M Sell
1,014,911
-153,172
-13% -$3.52M 0.02% 665
2014
Q4
$25.2M Buy
1,168,083
+148,700
+15% +$3.17M 0.02% 631
2014
Q3
$20.6M Buy
1,019,383
+265,700
+35% +$5.77M 0.02% 673
2014
Q2
$16.5M Buy
753,683
+79,700
+12% +$1.69M 0.02% 731
2014
Q1
$13.8M Buy
673,983
+117,726
+21% +$2.32M 0.01% 758
2013
Q4
$10.1M Sell
556,257
-69,105
-11% -$1.31M 0.01% 826
2013
Q3
$11.6M Sell
625,362
-97,071
-13% -$1.91M 0.01% 768
2013
Q2
$14.6M Buy
+722,433
New +$15.6M 0.02% 671

Other funds holding BMR

UBS AM's BMR Position: Q1 2016 in Review

UBS AM sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 631,593 shares — an estimated $15M sold.

UBS AM first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $25.2M in Q4 2014. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • UBS AM reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • UBS AM sold 631,593 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $15M.
  • UBS AM first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • UBS AM's BIOMED REALTY TRUST INC position peaked at $25.2M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.